Article de support · BPF / Annexe 1
A technical supplement for QA, validation, and operations teams—focused on GMP expectations, Annex 1 interpretation, and practical supplier qualification checkpoints for cleanroom mops.
This article serves as a technical supplement to the primary pharmaceutical cleanroom mop supplier guide, focusing specifically on GMP and Annex 1 interpretation.
In pharmaceutical manufacturing, mop selection directly affects the robustness of the cleaning validation program. Under the revised EU GMP Annex 1, regulators place increased scrutiny on how disinfectants are applied and how residues are removed as part of routine and sporicidal cleaning.
Si les substrats lient/neutralisent les actifs désinfectants, la concentration en surface peut tomber en dessous des objectifs de réduction logarithmique validés.
La perte de fibres augmente les particules non viables, augmentant ainsi le risque d'excursion EM et la charge d'enquête.
L’absence de documentation sur la traçabilité ou la stérilisation des vadrouilles est une source récurrente de constatations d’audit.
Although “mops” are not explicitly referenced in every clause, Annex 1 cleanroom cleaning requirements are inherently linked to the tools used to execute validated cleaning processes.
Annex 1 emphasizes that cleanroom design and equipment must facilitate effective cleaning. From a regulatory interpretation standpoint, this extends to tools that can access all relevant surfaces and are constructed from materials that do not harbor or generate contamination. In Grade A/B areas, contamination control principles require sterile tools introduced via a validated transfer process (e.g., double-bagged entry through an airlock). This places mop mechanical performance within the scope of cleaning process validation—not product selection alone.
Under GMP expectations, pharmaceutical cleaning tools must be manufactured from chemically inert materials. Natural fibers/foams/cellulose may degrade or interact with aggressive sporicides and high-concentration alcohols. GMP-compliant mop systems typically use knitted polyester for chemical resistance and low particle generation.
In Grade A/B cleanrooms, mops are expected to be sterile at the point of use. In Grade C/D, non-sterile but low-particulate mops may be acceptable when justified by risk assessment. For sterile applications, suppliers should provide sterilization validation—commonly gamma irradiation—demonstrating SAL 10⁻⁶ and batch-specific Certificates of Irradiation.
Double/triple bagging enables staged peel-and-transfer procedures; outer packaging is removed in lower grade areas and inner sterile bag opened only within Grade A/B. GMP also requires maintaining a defined “state of control”: mop heads delivered today must remain equivalent to those qualified during cleaning validation. Material/process/packaging changes should be governed under formal change control with advance notification.
Pour un cadre plus large sur l'évaluation des fournisseurs, reportez-vous au guide principal sur Sélection de fournisseurs de vadrouilles pour salles blanches pharmaceutiques.
Pour connaître les exigences en matière de documentation axée sur l'audit, voir Documents de validation des vadrouilles pour salles blanches et normes COA.
Supplier qualification under GMP and Annex 1 typically requires access to technical documentation and evaluation samples. You may request:
Remarque : Fournissez la qualité de votre salle blanche (A/B/C/D), la rotation des désinfectants, les exigences de stérilité et les contraintes SOP d'emballage/transfert pour un dossier de documentation précis.
Nous vous contacterons dans un délai d'un jour ouvrable, veuillez faire attention à l'e-mail avec le suffixe "*@midposi.com".
Optimized by Seraphinite Accelerator